Andrew A Hindman Net Worth & Insider Trades
Andrew A Hindman - Chief Business Officer, Acorda Therapeutics Inc
What is Andrew A Hindman's Net Worth?
The current estimated net worth of Acorda Therapeutics Inc's Chief Business Officer, Andrew A Hindman, is estimated to be about $3.41M . Andrew A Hindman owns about 5,171 units of Acorda Therapeutics Inc common stock. In the last 5 years at Acorda Therapeutics Inc, Andrew A Hindman has sold an estimated value of $1.59M worth.
What is Andrew A Hindman's Past Insider Trading?
Andrew A Hindman's largest sale order was 42,615 units , worth over $1.03M on May 30, 2018. In total, Andrew A Hindman has made about 19 transactions over 5 years of their time at Acorda Therapeutics Inc. Andrew A Hindman usually trades in May, with the busiest year in 2018. The most recent transaction was a sale order of 753 units , worth over $15.48K on December 6, 2018.
Andrew A Hindman
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Andrew A Hindman's' Mailing Address?
- Mailing address is C/o Acorda Therapeutics, Inc. 420 Saw Mill River Road Ardsley NY 10502 NY
What are Acorda Therapeutics Inc's Past Insider Trades?
Acorda Therapeutics Inc's most recent insider trade came on March 20, 2023 by Ron Cohen who bought 20,156 units worth $12.59K . In the last 17 years, insiders at Acorda Therapeutics Inc have sold an estimated value of $209.22M and bought an estimated value of $39.66M worth of shares. Insider trading is most common in June, with the busiest year in 2018. The most active traders at the company are David Lawrence, Chief, Ron Cohen, President and CEO, and Jane Wasman, President .
Acorda Therapeutics, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||